e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2017 , Vol 25 , Num 2
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
Actual Treatment for ROP
İmren AKKOYUN
Başkent Üniversitesi Tıp Fakültesi Göz Hastalıkları Anabilim Dalı, Ankara Retinopathy of prematurity (ROP) is the major cause of visuel impairment and blindness in prematu re neonates. ROP is a complex multifactorial diesease with microvascular dejeneration at diff erent stages followed by neovascularisation and some cases resulting in retinal detachment. Current standart ablative therapy, like laser photocaogulation for proliferative ROP have limitations and patients can stil have long-term complications despite successful treatment. Based on knowledge on ROP patophysiology new treatment modalities are developing. Intravitreal anti-VEGF therapy has been proven to be more eff ective in terms of lowering recurrence, rates allowing growth of the peripheral retina, and diminishing the incidence of retinal detachment when proliferative ROP was diagnosed, more particularly in Zon-I- ROP and AP-ROP. Whether anti-VEGF plus laser are better options than any of these therapies separately remains a subject of discussion. First results of intravitreal anti-VEGF therapy using anti-VEGF are promising. The importance of fl uorescein angiography in long term-follow up after intravitreal anti-VEGF injection has be clarified. All eff ors should be investigated in developing new therapy modalities including management algorith in current ROP treatment. Keywords : ROP, laserphotocoagulation, anti-VEGF
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact